Click here to read the full article.

White House drug czar Jim Carroll toldPoliticoearlier this week that an Office of National Drug Control Policy analysis findsan 11.4 percent yearoveryear increase in opioidrelated overdose deaths during the first four months of 2020. Kentucky has seen a25 percent increase in overdose deaths during the first four months of this year, and West Virginia saw a50 percent increase in deaths since the beginning of the year. The data are incomplete at this point, and not all states have reported in.

Mr. Carroll attributed much of the increase in the overdose rate to anxiety, social isolation, and depression resulting from the COVID-19 pandemic. But he also noted that, after aoneyear pause in 2017, the overdose death rate resumed its climb inlate 2018 and 2019. And methamphetaminerelated deaths have been surging for the past few years.

Researchhas shown that overdose deaths from the nonmedical use of licit or illicit drugs have been on asteady exponential increase since at least the late 1970swith different drugs predominating at different periods. And there is no evidence the trend is slowing.

While it remains popular to attribute the opioidrelated overdose crisis to doctors prescribing pain relievers to patients, the evidenceshowsthere is no correlation between prescription volume and the nonmedical opioid use or opioid use disorder.

To be sure, the COVID-19 pandemic is exacerbating the situation. People with substance use disorder need to feel connectedness with others as well as themselves to overcome the problem.Isolation, loneliness, and the anxiety and depressionassociated with quarantines, lockdowns, and the resultant economic dislocations are the opposite of what people suffering from addiction require.

Add to that the fact that the pandemic response hashampered the smooth operation of harm reduction programs, despite efforts to mitigate the disruption with the temporaryrelaxationof many federal regulations. And the Substance Abuse and Mental Health Services Administrationreportsthe sobering fact that many first responders are reluctant to respond to overdose calls with the antidote naloxone, fearing they may contract COVID-19 during the resuscitative process. Of course, this is yet another argument for having the Food and Drug Administration reclassify naloxone asover the counter.

Story continues

But it should not go without notice that many chronic pain patients have been unable to follow up with their physicians, whose offices have been closed (or office hours restricted) in order to reduce the spread of COVID-19. And many elective procedures to treat or eliminate these painful conditions have been postponed or cancelled because of blanket bans on elective procedures. This was discussed at aCato onlineeventin May. In desperation, many patients might be seeking relief in the dangerous black market fueled by drug prohibition.

Speaking of prohibition, the drug czar told Politico that the pandemic response has caused Customs and Border Patrol agents to reduce screening for drugs smuggled across the border.

The effect of the COVID-19 pandemic on substance use, substance use disorder, and overdose deaths must not be ignored or underemphasized. But, at the end of the day, thedriving forcebehind overdose deaths has always beendrug prohibition. Andso it will remain, until it is repealed.

This article by Jeffrey A. Singer firstappearedinCATOon July 1, 2020.

Image: Reuters.

Click here to read the full article.

Follow this link:

Don't Blame the Wave of Overdose Deaths on Coronavirus LockdownBlame Them On the War On Drugs - Yahoo News